3 ASX 300 healthcare share winners on Wednesday

Which trio of healthcare shares flew higher today?

| More on:
A group of people in a corporate setting do a collective high five.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Three ASX 300 healthcare shares outperformed their sector in today's trading
  • Two of these companies received positive coverage from brokers this morning
  • Healthcare shares tend to outperform shares in other sectors in an economic downturn

Three S&P/ASX 300 Index (ASX: XKO) healthcare shares were flying higher than their peers this afternoon.

This may be surprising as the S&P/ASX 200 Health Care Index (ASX: XHJ) spent a great deal of its trading session in the red today, even notching the title of worst performing sector at one stage. However, a late rally saw the index close lightly in the green, up 0.17%.

On a broader level, the S&P/ASX 300 Index also struggled, closing 1.4% lower at the end of trading.

Healthcare and other defensive shares, such as consumer staples, tend to outperform other sectors during an economic downturn.

So it's possible that shares of healthcare companies may rise higher in the months ahead following anticipated interest rate hikes in Australia and inflation predicted to surge higher in the United States.

But for now, let's recap the healthcare shares that performed strongly on Wednesday.

Ramsay Health Care (ASX: RHC)

Ramsay managed to outperform the Health Care Index and ASX 300 today, closing 0.35% higher for the day at $71 apiece.

The company was featured in a Foolish article this morning in which a Shaw and Partners senior investment advisor said that its outlook looks bright after beating off headwinds of COVID-19.

Shares in the private hospital operator are down 1.21% year to date.

Resmed CDI (ASX: RMD)

The Resmed share price had a cracker of a day today, closing a hefty 4.23% higher at $33.51 and snatching poll position as today's top performing ASX 200 share. Earlier, shares in the medical equipment company lifted to an intraday high of $33.86 apiece.

Resmed also received some positive coverage from a broker this morning. Morgans said that the outlook for the company was positive, stating:

While we expect the next few quarters to be volatile as COVID-related demand for ventilators continues to slow and core sleep apnoea volumes gradually lift, nothing changes our medium/longer term view that the company remains well-placed as it builds a unique, patient-centric, connected-care digital platform that addresses the main pinch points across the healthcare value chain.

The company's shares are down 7.38% year to date.

Polynovo Ltd (ASX: PNV)

Polynovo shares were up 0.77%, trading at $1.31 apiece at the close on Wednesday. The company produces medical devices.

There has been no news from Polynovo today, nor has a broker covered the company recently. The most recent announcement was made on 26 August, when the company announced its results for FY22.

Polynovo reported a surge in revenues for the reporting period as it grew 42.8%. However, investors sent its shares plummeting 15% on the day of the announcement.

Polynovo plans to expand its presence in the United States, New Zealand, and Australian markets.

The company's shares are down 16% year to date.

Motley Fool contributor Matthew Farley has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended POLYNOVO FPO and ResMed Inc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed Inc. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

CSL share price leaping higher amid $1.9 billion funding news

ASX 200 investors are bidding up the CSL share price on Wednesday.

Read more »

Two happy scientists analysing test results.
Healthcare Shares

Mesoblast share price rockets 36% on breaking FDA news

ASX investors are sending the Mesoblast share price soaring following promising FDA news.

Read more »

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
Healthcare Shares

Guess which ASX 200 healthcare share is jumping 7% on a guidance update

This healthcare share is performing better than expected in FY 2024.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Earnings Results

Chemist Warehouse merger target Sigma reports 149% FY24 profit jump

This could be the last set of results from Sigma as we know it if its merger is approved.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

1 ASX healthcare stock that looks severely undervalued

I think this stock looks too cheap to miss.

Read more »

Stethoscope with a piggy bank and hundred dollar notes.
Healthcare Shares

Own Medibank shares? Here's why it's a rewarding day for you

Shareholders are getting a healthy boost today.

Read more »

Health professional looking at a laptop.
Healthcare Shares

Are CSL shares a must-buy in March?

Let's see what analysts are saying about this high-quality company.

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

This ASX healthcare stock is up 72% on FDA news and 'historic moment'

Huge gains are been recorded by this stock on Tuesday. But why?

Read more »